Individual risk factors for venous thromboembolism (VTE) in cancer patients treated with targeted therapies (TT)

被引:0
|
作者
Soini, B.
Caffo, O.
Ferro, A.
Ambrosini, G.
Murgia, V.
Valduga, F.
Caldara, A.
Eccher, C.
Tumulo, S.
Galligioni, E.
机构
[1] Santa Chiara Hosp, Trento, Italy
[2] Fdn Bruno Kessler, Trento, Italy
[3] S Maria Angeli Hosp, Pordenone, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e20549
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Venous Thromboembolism (VTE) In Patients With Pancreatic Cancer
    Kim, Kyoung Ha
    Yoon, Seug Yun
    Yoon, Jina
    Kim, Han Jo
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan-Kyu
    Lee, Namsu
    Park, Sung Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    BLOOD, 2013, 122 (21)
  • [12] VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH PANCREATIC CANCER
    Kim, K. H.
    Yoon, S. Y.
    Yoon, J.
    Kim, H. J.
    Kim, S. H.
    Kim, H. J.
    Lee, S. C.
    Bae, S. B.
    Kim, C. K.
    Lee, N.
    Park, S. K.
    Won, J. H.
    Hong, D. S.
    Park, H. S.
    HAEMATOLOGICA, 2014, 99 : 780 - 781
  • [13] A PHARMACOECONOMIC ANALYSIS OF PROPHYLAXIS THERAPIES AND TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) IN MEXICAN PATIENTS WITH CANCER
    Arreola-Ornelas, H.
    Rosado-Buzzo, A. A.
    Garcia-Mollinedo, M. D. L.
    Dorantes-Aguilar, J.
    Mould-Quevedo, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2009, 12 (03) : A151 - A151
  • [14] VTE Recurrence and Safety of Anticoagulants Among Patients with Cancer Treated for Venous Thromboembolism
    Khorana, Alok A.
    McCrae, Keith
    Milentijevic, Dejan
    McCormick, Nora
    Laliberte, Francois
    Crivera, Concetta
    Lefebvre, Patrick
    Lejeune, Dominique
    Rozjabek, Heather
    Schein, Jeff
    Streiff, Michael B.
    BLOOD, 2017, 130
  • [15] Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk
    Liebman, Howard A.
    THROMBOSIS RESEARCH, 2018, 164 : S19 - S22
  • [16] Venous Thromboembolism (VTE) in Patients With Cholangiocarcinoma: Focus on Risk Factors and Impact on Survival
    Choi, Mun Ki
    Kim, Dong Uk
    Jeon, Hye Kyung
    Lee, Bong Eun
    Kim, Gwang Ha
    Song, Geun Am
    Kang, Dae Hwan
    GASTROENTEROLOGY, 2012, 142 (05) : S452 - S452
  • [17] Venous thromboembolism (VTE) is a rare complication without apparent risk factors in Japanese myeloma patients treated with thalidomide
    Kato, A.
    Hattori, K.
    Mikoshiba, M.
    Takano, H.
    Nakane, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 403 - 404
  • [18] Hereditary risk factors of thrombophilia and the individual probability of first venous thromboembolism (VTE) in pregnancy and puerperium
    Gerhardt, A.
    Scharf, R. E.
    Zotz, R. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 221 - 221
  • [19] Risk factors of recurrence in patients with cancer-associated venous thromboembolism: from the COMMAND VTE Registry
    Nishimoto, Y.
    Yamashita, Y.
    Morimoto, T.
    Saga, S.
    Sato, Y.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2842 - 2842
  • [20] Factors That Predict The Risk Of Recurrent Venous Thromboembolism (VTE) In Patients With VTE And Factor V Leiden (FVL)
    Couturaud, F.
    Noel-Savina, E.
    Paleiron, N.
    Quere, G.
    Mottier, D.
    Leroyer, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181